Hi Patrick,
The British medical journal The Lancet reported the clinical trial results of an experimentalEbolavaccine tested last year in the West African nation of Guineaduring the continuingoutbreak of the viral diseasethat had shown promising initial results.
The clinical trial included the use of a beer-keg-shaped vaccine storage device, the Arktek. It allowed the vaccines to be transported and kept at minus 80 degrees in outlying areas without electricity for many days, which was deemed necessary because the vaccine’s stability at higher temperatures had not yet been fully tested. The storage device was invented by Global Good, and developed/manufactured by Aucma in China.
The New York Times published the story on July 15, 2015. Here is the link: http://www.nytimes.com/2015/08/01/world/africa/experimental-ebola-vaccine-in-guinea-shows-promise-report-says.html?register=google&_r=2
Anyone who wants to know more about the Arktek product should visit website www.arktek.org, or www.globalgood.com. They can also email Arktek@intven.com for more information.
Best regards,
Zihong Guo